Natixis’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-11,164
Closed -$79K 1338
2017
Q3
$79K Buy
+11,164
New +$79K ﹤0.01% 1198
2014
Q4
Sell
-14,300
Closed -$197K 449
2014
Q3
$197K Buy
+14,300
New +$197K ﹤0.01% 389